{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:00:49Z","timestamp":1793041249826,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["BPD 00733-22"],"award-info":[{"award-number":["BPD 00733-22"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["\/ BFP- 0002-5\/21"],"award-info":[{"award-number":["\/ BFP- 0002-5\/21"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuro.2024.08.002","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:10:44Z","timestamp":1724472644000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Use of phytocanabinoids in animal models of Parkinson's disease: Systematic review"],"prefix":"10.1016","volume":"105","author":[{"given":"Amanda de Deus Ferreira","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Carolina Ribeiro","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pabyton Gon\u00e7alves","family":"Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdemiro Amaro","family":"Silva-Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2024.08.002_bib1","first-page":"45","article-title":"Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice","volume":"11","author":"Abdel-Salam","year":"2012","journal-title":"EXCLI J."},{"issue":"2","key":"10.1016\/j.neuro.2024.08.002_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"15","key":"10.1016\/j.neuro.2024.08.002_bib3","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/molecules24152702","article-title":"Development of an oral treatment with the PPAR-\u03b3-acting cannabinoid VCE-003.2 against the inflammation-driven neuronal deterioration in experimental Parkinson\u2019s disease","volume":"24","author":"Burgaz","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuro.2024.08.002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103583","article-title":"Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson\u2019s disease using 6-hydroxydopamine-lesioned mice","volume":"110","author":"Burgaz","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.neuro.2024.08.002_bib5","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.3390\/molecules26113245","article-title":"Neuroprotection with the cannabidiol quinone derivative VCE-004.8 (EHP-101) against 6-hydroxydopamine in cell and murine models of Parkinson\u2019s disease","volume":"26","author":"Burgaz","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.neuro.2024.08.002_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neuropharm.2017.08.017","article-title":"GPR55: a therapeutic target for Parkinson's disease?","volume":"125","author":"Celorrio","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2024.08.002_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2016.06.013","article-title":"Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action","volume":"94","author":"dos-Santos-Pereira","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2024.08.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104892","article-title":"Beneficial effects of the phytocannabinoid \u03949-THCV in L-DOPA-induced dyskinesia in Parkinson's disease","volume":"141","author":"Espadas","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2024.08.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135534","article-title":"\u03b2-Caryophyllene exerts protective antioxidant effects through the activation of NQO1 in the MPTP model of Parkinson's disease","volume":"742","author":"Flores-Soto","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2024.08.002_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8173876","article-title":"Euterpe edulis extract but not oil enhances antioxidant defenses and protects against nonalcoholic fatty liver disease induced by a high-fat diet in rats","volume":"2016","author":"Freitas","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.neuro.2024.08.002_bib11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid \u0394 9-THCV in animal models of Parkinson's disease","volume":"163","author":"Garc\u00eda","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1)","key":"10.1016\/j.neuro.2024.08.002_bib12","first-page":"162","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2006","journal-title":"Brain Res."},{"issue":"16","key":"10.1016\/j.neuro.2024.08.002_bib13","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.3390\/ijms22168920","article-title":"Neuroprotective and symptomatic effects of cannabidiol in an animal model of Parkinson's Disease","volume":"22","author":"Giuliano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuro.2024.08.002_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pnpbp.2013.06.005","article-title":"Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice","volume":"46","author":"Gomes","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuro.2024.08.002_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainres.2005.04.010","article-title":"Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blokcade of these receptors in parkin-null mice","volume":"1046","author":"Gonz\u00e1lez","year":"2005","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neuro.2024.08.002_bib16","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1007\/s11064-023-03899-8","article-title":"The effects of chronic marijuana administration on 6-OHDA-induced learning & memory impairment and hippocampal dopamine and cannabinoid receptors interaction in male rats","volume":"48","author":"Haghparast","year":"2023","journal-title":"Neurochem. Res."},{"issue":"43","key":"10.1016\/j.neuro.2024.08.002_bib17","first-page":"1","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.neuro.2024.08.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113342","article-title":"Marijuana improved motor impairments and changes in synaptic plasticity-related molecules in the striatum in 6-OHDA-treated rats","volume":"410","author":"Komeili","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.neuro.2024.08.002_bib19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.neuro.2024.08.002_bib20","first-page":"1","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.neuro.2024.08.002_bib21","first-page":"5","article-title":"Uso da Cannabis medicinal e autismo","volume":"2","author":"Lima","year":"2020","journal-title":"J. Meml. da Med."},{"key":"10.1016\/j.neuro.2024.08.002_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.22159\/ajpcr.2017.v10i7.18276","article-title":"Relevance and perspectives of experimental wound models in wound healing research","volume":"10","author":"Lodhi","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"6","key":"10.1016\/j.neuro.2024.08.002_bib23","doi-asserted-by":"crossref","first-page":"41510","DOI":"10.34117\/bjdv6n6-623","article-title":"Uso medicinal da Cannabis sativa (Cannabaceae) como alternativa no tratamento da epilepsia","volume":"6","author":"Medeiros","year":"2020","journal-title":"Braz. J. Dev."},{"key":"10.1016\/j.neuro.2024.08.002_bib24","doi-asserted-by":"crossref","first-page":"5792014","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: A comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Health Serv. Res."},{"issue":"5","key":"10.1016\/j.neuro.2024.08.002_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0091-3057(81)90022-8","article-title":"Tetrahydrocannabinol potentiates reserpine-induced hypokinesia","volume":"15","author":"Moss","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2024.08.002_bib26","article-title":"Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease","volume":"163","author":"Nascimento","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2024.08.002_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-016-2733-y","article-title":"\u03b2-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease","volume":"418","author":"Ojha","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.neuro.2024.08.002_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(89)90597-0","article-title":"A 6-hydroxydopamine-induced selective parkinsonian rat model","volume":"494","author":"Perese","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2024.08.002_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Ann. N. Y. Acad. Sci. J."},{"issue":"1","key":"10.1016\/j.neuro.2024.08.002_bib30","first-page":"46","article-title":"O uso do canabidiol (CBD) no tratamento da doen\u00e7a de Parkinson e suas comorbidades","volume":"98","author":"Santos","year":"2019","journal-title":"Rev. De. Med."},{"issue":"7","key":"10.1016\/j.neuro.2024.08.002_bib31","article-title":"The use of cannabis in the treatment of Alzheimer","volume":"11","author":"Santos","year":"2022","journal-title":"Res., Soc. Dev."},{"key":"10.1016\/j.neuro.2024.08.002_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP.","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuro.2024.08.002_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuro.2024.08.002_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.euroneuro.2007.11.003","article-title":"Therapeutic effects of A9-THC and modafinil in a marmoset Parkinson model","volume":"18","author":"van-Vliet","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuro.2024.08.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108700","article-title":"Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats","volume":"196","author":"Vivanco-Estela","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2024.08.002_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroscience.2022.06.036","article-title":"Cannabidiol alleviates the damage to dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinson's disease mice via regulating neuronal apoptosis and neuroinflammation","volume":"498","author":"Wang","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2024.08.002_bib37","article-title":"Effects of cannabidiol on Parkinson\u2019s disease in a transgenic mouse model by gut-brain metabolic analysis","volume":"2022","author":"Zhao","year":"2022","journal-title":"Evid. -Based Complement. Altern. Med."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X24000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X24000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:43:27Z","timestamp":1734000207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X24000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"alternative-id":["S0161813X24000986"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2024.08.002","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of phytocanabinoids in animal models of Parkinson's disease: Systematic review","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2024.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}